Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors

Abstract

Testicular germ cell tumors (TGCTs) are a cancer pharmacology success story with a majority of patients cured even in the highly advanced and metastatic setting. Successful treatment of TGCTs is primarily due to the exquisite responsiveness of this solid tumor to cisplatin-based therapy. However, a significant percentage of patients are, or become, refractory to cisplatin and die from progressive disease. Mechanisms for both clinical hypersensitivity and resistance have largely remained a mystery despite the promise of applying lessons to the majority of solid tumors that are not curable in the metastatic setting. Recently, this promise has been heightened by the realization that distinct (and perhaps pharmacologically replicable) epigenetic states, rather than fixed genetic alterations, may play dominant roles in not only TGCT etiology and progression but also their curability with conventional chemotherapies. In this review, it discusses potential mechanisms of TGCT cisplatin sensitivity and resistance to conventional chemotherapeutics.

Keywords

Testicular cancer / embryonal carcinoma / cisplatin / resistance / epigenetics / testicular germ cell tumors / DNA methylation / p53

References

[1] Ghazarian AA,Altekruse SF,McGlynn KA.Future of testicular germ cell tumor incidence in the United States: Forecast through 2026..Cancer2017;123:2320-8 PMCID:PMC5629636

[2] Adra N.Testicular cancer update..Clin Adv Hematol Oncol2017;15:386-96

[3] Giuliano CJ,Spinella MJ.Testicular germ cell tumors: A paradigm for the successful treatment of solid tumor stem cells..Curr Cancer Ther Rev2006;2:255-70 PMCID:PMC3904303

[4] Allen JC,Scarpato KR.Current management of refractory germ cell tumors and future directions..Curr Oncol Rep2017;19:8

[5] Einhorn LH,Chamness A,Perkins SM.High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors..N Engl J Med2007;357:340-8

[6] Feldman DR,Bajorin DF,Turkula S.TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis..J Clin Oncol2010;28:1706-13 PMCID:PMC3651604

[7] Oing C,von Amsberg G,Bokemeyer C.Platinum-refractory germ cell tumors: an update on current treatment options and developments..World J Urol2017;35:1167-75

[8] Albers P,Algaba F,Cohn-Cedermark G.Guidelines on testicular cancer: 2015 update..Eur Urol2015;68:1054-68

[9] Znaor A,Jemal A.International variations and trends in testicular cancer incidence and mortality..Eur Urol2014;65:1095-106

[10] Abouassaly R,Giwercman A,Motzer RJ.Sequelae of treatment in long-term survivors of testis cancer..Eur Urol2011;60:516-26

[11] Tandstad T,Roth BJ,Gillessen S.Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm..J Clin Oncol2017;35:3525-28 PMCID:PMC5791831

[12] Schmidtova S,Kucerova L.Molecular mechanisms of cisplatin chemoresistance and its circumventing in testicular germ cell tumors..Curr Oncol Rep2018;20:88

[13] Berney DM,Idrees M,Rajpert-De Meyts E.Germ cell neoplasia in situ (GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy..Histopathology2016;69:7-10

[14] Spiller CM.Germ cell neoplasia in situ: The precursor cell for invasive germ cell tumors of the testis..Int J Biochem Cell Biol2017;86:22-5

[15] Mitchell RT,Macdonald J,Kelnar CJ.Intratubular germ cell neoplasia of the human testis: heterogeneous protein expression and relation to invasive potential..Mod Pathol2014;27:1255-66 PMCID:PMC4012991

[16] Kristensen DM,Ottesen AM,Nielsen JE.Origin of pluripotent germ cell tumours: the role of microenvironment during embryonic development..Mol Cell Endocrinol2008;288:111-8

[17] Spierings DC,Vellenga E.The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuli..J Pathol2003;200:137-48

[18] Kalavska K,De Giorgi U.Molecular mechanisms of resistance in testicular germ cell tumors - clinical implications..Curr Cancer Drug Targets2018;18:967-78

[19] Litchfield K,Yost S,Labreche K.Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours..Nat Commun2015;6:5973 PMCID:PMC4338546

[20] Shen H,Hollern DP,Bowlby R.Integrated molecular characterization of testicular germ cell tumors..Cell Rep2018;23:3392-406 PMCID:PMC6075738

[21] Bulic-Jakus F,Juric-Lekic G,Sincic N.Teratoma: from spontaneous tumors to the pluripotency/malignancy assay..Wiley Interdiscip Rev Dev Biol2016;5:186-209

[22] Andrews PW,Bahrami AR,Gokhale P.Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin..Biochem Soc Trans2005;33:1526-30

[23] Bray F,Soerjomataram I,Torre LA.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries..CA Cancer J Clin2018;68:394-424

[24] Ferguson L.Testicular cancer and cryptorchidism..Front Endocrinol (Lausanne)2013;4:32 PMCID:PMC3602796

[25] Dieckmann KP,Henke RP.Association of Down’s syndrome and testicular cancer..J Urol1997;157:1701-4

[26] Soto AM.Environmental causes of cancer: endocrine disruptors as carcinogens..Nat Rev Endocrinol2010;6:363-70 PMCID:PMC3933258

[27] Piltoft JS,Dalton SO,Baker JL.Early life risk factors for testicular cancer: a case-cohort study based on the Copenhagen School Health Records Register..Acta Oncol2017;56:220-4

[28] Cook MB,Forman D,Richiardi L.A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer experiences of the son..Int J Epidemiol2010;39:1605-18 PMCID:PMC2992627

[29] Maule M,Richiardi L.Age at puberty and risk of testicular cancer: a meta-analysis..Int J Androl2012;35:828-34

[30] Moller H.Risk of testicular cancer in subfertile men: case-control study..BMJ1999;318:559-62 PMCID:PMC27753

[31] Jacobsen R,Engholm G,Olsen JH.Risk of testicular cancer in men with abnormal semen characteristics: cohort study..BMJ2000;321:789-92 PMCID:PMC27489

[32] Hanson HA,Aston KI,Smith KR.Subfertility increases risk of testicular cancer: evidence from population-based semen samples..Fertil Steril2016;105:322-8 PMCID:PMC4744156

[33] Zequi Sde C,Santana TB,Sacomani CA.Bilateral testicular germ cell tumours: a systematic review..BJU Int2012;110:1102-9

[34] Sperger JM,Draper JS,Chon CH.Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors..Proc Natl Acad Sci U S A2003;100:13350-5 PMCID:PMC263817

[35] Josephson R,Liu Y,Lakshmipathy U.Qualification of embryonal carcinoma 2102Ep as a reference for human embryonic stem cell research..Stem Cells2007;25:437-46

[36] Atkin NB.Specific chromosome change, i(12p), in testicular tumours?.Lancet1982;2:1349

[37] Facchini G,Cavaliere C,Di Franco R.Exploring the molecular aspects associated with testicular germ cell tumors: a review..Oncotarget2018;9:1365-79 PMCID:PMC5787445

[38] Oosterhuis JW.Testicular germ-cell tumours in a broader perspective..Nat Rev Cancer2005;5:210-22

[39] Baker DE,Maltby E,Moore HD.Adaptation to culture of human embryonic stem cells and oncogenesis in vivo..Nat Biotechnol2007;25:207-15

[40] FireBrowse portal. Available from https://firebrowse.org/

[41] Skakkebaek NE,Giwercman A.Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma..Int J Androl1987;10:19-28

[42] Rijlaarsdam MA.An oncofetal and developmental perspective on testicular germ cell cancer..Semin Cancer Biol2014;29:59-74

[43] Litchfield K,Huddart RA,Turnbull C.The genomic landscape of testicular germ cell tumours: from susceptibility to treatment..Nat Rev Urol2016;13:409-19

[44] Honecker F,de Krijger RR,Bokemeyer C.Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells..J Pathol2004;203:849-57

[45] Batool A,Wu XN,Liu YX.Testicular germ cell tumor: a comprehensive review..Cell Mol Life Sci2019;76:1713-27

[46] Skakkebaek NE,Jorgensen N,Petersen PM.Germ cell cancer and disorders of spermatogenesis: an environmental connection?.APMIS1998;106:3-11

[47] Oosterhuis JW,Honecker F.Why human extragonadal germ cell tumours occur in the midline of the body: old concepts, new perspectives..Int J Androl2007;30:256-63

[48] Pierce JL,Amatruda JF.Pediatric germ cell tumors: a developmental perspective..Adv Urol2018;2018:9059382 PMCID:PMC5817207

[49] Kanetsky PA,Vardhanabhuti S,Vaughn DJ.Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer..Nat Genet2009;41:811-5 PMCID:PMC2865677

[50] Mintz B.Normal genetically mosaic mice produced from malignant teratocarcinoma cells..Proc Natl Acad Sci U S A1975;72:3585-9 PMCID:PMC433040

[51] Lobo J,Jerónimo C,Looijenga LH.Human germ cell tumors are developmental cancers: Impact of epigenetics on pathobiology and clinic..Int J Mol Sci2019;20:pii: E258 PMCID:PMC6359418

[52] Killian JK,Trabert B,Cook MB,Meltzer PS,Looijenga LH.Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors..Genome Res2016;26:1490-504 PMCID:PMC5088592

[53] Rijlaarsdam MA,Gillis AJ,Koestler DC.Genome wide DNA methylation profiles provide clues to the origin and pathogenesis of germ cell tumors..PLoS One2015;10:e0122146 PMCID:PMC4479500

[54] van der Zwan YG,Rossello FJ.Seminoma and embryonal carcinoma footprints identified by analysis of integrated genome-wide epigenetic and expression profiles of germ cell cancer cell lines..PLoS One2014;9:e98330 PMCID:PMC4041891

[55] Smiraglia DJ,Kraggerud SM,Peltomaki P.Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors..Oncogene2002;21:3909-16

[56] Pinney SE.Mammalian non-CpG methylation: Stem cells and beyond..Biology (Basel)2014;3:739-51 PMCID:PMC4280509

[57] Grossniklaus U.Transcriptional silencing by polycomb-group proteins..Cold Spring Harb Perspect Biol2014;6:a019331 PMCID:PMC4413232

[58] Schuettengruber B,Di Croce L.Genome regulation by polycomb and trithorax: 70 years and counting..Cell2017;171:34-57

[59] Sashida G,Iwama A.Deregulated Polycomb functions in myeloproliferative neoplasms..Int J Hematol2019;

[60] Wang W,Voruganti S,Zhou J.Polycomb group (PcG) proteins and human cancers: Multifaceted Functions and therapeutic implications..Med Res Rev2015;35:1220-67 PMCID:PMC4718713

[61] Jostes S,Schorle H.Epigenetic drugs and their molecular targets in testicular germ cell tumours..Nat Rev Urol2019;16:245-59

[62] Almstrup K,Mlynarska O,Jorgensen A.Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells..Br J Cancer2010;103:1269-76 PMCID:PMC2967056

[63] Hoang N,Zhang C,Leng F.New histone demethylase LSD1 inhibitor selectively targets teratocarcinoma and embryonic carcinoma cells..Bioorg Med Chem2018;26:1523-37 PMCID:PMC6071666

[64] Yin F,Zhang X,Chen F.LSD1 regulates pluripotency of embryonic stem/carcinoma cells through histone deacetylase 1-mediated deacetylation of histone H4 at lysine 16..Mol Cell Biol2014;34:158-79 PMCID:PMC3911295

[65] Voorhoeve PM,Schrier M,Stoop H.A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors..Cell2006;124:1169-81

[66] Syring I,Holdenrieder S,Muller SC.Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer..J Urol2015;193:331-7

[67] Dieckmann KP,Geczi L,Anheuser P.Serum levels of microRNA-371a-3p (M371 test) as a new biomarker of testicular germ cell tumors: results of a prospective multicentric study..J Clin Oncol2019;37:1412-23 PMCID:PMC6544462 [Available on 2020-06-01]

[68] International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group..J Clin Oncol1997;15:594-603

[69] Rick O,Beyer J,Schwella N.Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer..J Clin Oncol2001;19:81-8

[70] Galluzzi L,Vitale I,Martins I.Molecular mechanisms of cisplatin resistance..Oncogene2012;31:1869-83

[71] Fenske AE,Bokemeyer C,Dahm-Daphi J.Cisplatin resistance induced in germ cell tumour cells is due to reduced susceptibility towards cell death but not to altered DNA damage induction or repair..Cancer Lett2012;324:171-8

[72] Safaei R.Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs..Crit Rev Oncol Hematol2005;53:13-23

[73] Sark MW,Meijer C,Sluiter WJ.Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines..Br J Cancer1995;71:684-90 PMCID:PMC2033748

[74] Masters JR,Hall AG,Matheson EC.Sensitivity of testis tumour cells to chemotherapeutic drugs: role of detoxifying pathways..Eur J Cancer1996;32A:1248-53

[75] Mayer F,Scheffer GL,Oosterhuis JW.Molecular determinants of treatment response in human germ cell tumors..Clin Cancer Res2003;9:767-73

[76] Pera MF,Mills J.Inherent sensitivity of cultured human embryonal carcinoma cells to adducts of cis-diamminedichloroplatinum(II) on DNA..Cancer Res1987;47:6810-3

[77] Bedford P,Shellard SA,Masters JR.Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines..Cancer Res1988;48:3019-24

[78] Hill BT,Hansson J,Pera M.Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients..Eur J Cancer1994;30A:832-7

[79] Wood RD,Ariza RR,Biggerstaff M.DNA damage recognition and nucleotide excision repair in mammalian cells..Cold Spring Harb Symp Quant Biol2000;65:173-82

[80] Shuck SC,Turchi JJ.Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology..Cell Res2008;18:64-72 PMCID:PMC2432112

[81] Awuah SG,Lippard SJ.Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity..Proc Natl Acad Sci U S A2017;114:950-5 PMCID:PMC5293106

[82] Kartalou M.Recognition of cisplatin adducts by cellular proteins..Mutat Res2001;478:1-21

[83] Jung Y.Direct cellular responses to platinum-induced DNA damage..Chem Rev2007;107:1387-407

[84] Yamada M,Brown R.Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins..Nucleic Acids Res1997;25:491-6 PMCID:PMC146450

[85] Shu X,Song J,Yi C.Base-Resolution Analysis of Cisplatin-DNA Adducts at the Genome Scale..Angew Chem Int Ed Engl2016;55:14246-9 PMCID:PMC5131569

[86] Bloom JC,Schimenti JC.Germline genome protection: implications for gamete quality and germ cell tumorigenesis..Andrology2019;

[87] Honecker F,Mayer F,Stoop H.Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors..J Clin Oncol2009;27:2129-36

[88] Rudolph C,Nielsen JE.Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours..Cell Oncol (Dordr)2017;40:341-55

[89] Mayer F,Dinjens W,Bokemeyer C.Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment..Cancer Res2002;62:2758-60

[90] Velasco A,Schultz M,Villarroel L.Microsatellite instability and loss of heterozygosity have distinct prognostic value for testicular germ cell tumor recurrence..Cancer Biol Ther2004;3:1152-8

[91] Mego M,Svetlovska D,Machalekova K,Chovanec M,Obertova J,Mardiak J.PARP expression in germ cell tumours..J Clin Pathol2013;66:607-12

[92] Cavallo F,Antinozzi C,Houldsworth J.Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition..PLoS One2012;7:e51563 PMCID:PMC3520950

[93] Kersemaekers AM,Molier M,Oosterhuis JW.Role of P53 and MDM2 in treatment response of human germ cell tumors..J Clin Oncol2002;20:1551-61

[94] Kerley-Hamilton JS,Li N,Spinella MJ.A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma..Oncogene2005;24:6090-100

[95] Gutekunst M,Weilbacher A,Markwardt C.p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin..PLoS One2011;6:e19198 PMCID:PMC3080918

[96] Romano FJ,Conteduca V,Cavaliere C.Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review..Oncotarget2016;7:85641-9 PMCID:PMC5356765

[97] Duale N,Komada M,Andreassen A.Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles..Mol Cancer.2007;6:53 PMCID:PMC1988831

[98] Bagrodia A,Lee W,Sfakianos JP.Genetic determinants of cisplatin resistance in patients with advanced germ cell tumors..J Clin Oncol2016;34:4000-7 PMCID:PMC5477828

[99] Taylor-Weiner A,O’Donnell E,Bernard B.Genomic evolution and chemoresistance in germ-cell tumours..Nature2016;540:114-8 PMCID:PMC5553306

[100] Koster R,Bischoff R,de Jong S.Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway..Cell Death Dis2011;2:e148 PMCID:PMC3122064

[101] Grande L,Rosa-Garrido M,Hernandez T.Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin..J Biol Chem2012;287:26495-505 PMCID:PMC3410991

[102] Beyer U,Moll UM.Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes..Proc Natl Acad Sci U S A2011;108:3624-9 PMCID:PMC3048127

[103] Noel EE,Mao X,Kudahetti SC.The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers..Am J Pathol2010;176:2607-15 PMCID:PMC2877824

[104] Selfe J,McIntyre A,Renshaw J.IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance..J Pathol2018;244:242-53 PMCID:PMC5817239

[105] Di Vizio D,Boccia A,Insabato L.Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors..Oncogene2005;24:1882-94

[106] Koster R,Timmer-Bosscha H,van den Berg A.Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer..J Clin Invest2010;120:3594-605 PMCID:PMC2947220

[107] Juliachs M,Moutinho CA,Condom E.The PDGFRbeta-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors..Clin Cancer Res2014;20:658-67

[108] Feldman DR,Van Alstine L,Al-Ahmadie H.Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors..Clin Cancer Res2014;20:3712-20

[109] Castillo-Avila W,Garcia Del Muro X,Condom E.Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors..Clin Cancer Res2009;15:3384-95

[110] Juliachs M,Del Muro XG,Condom E.Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors..BMC Cancer2013;13:382 PMCID:PMC3751347

[111] Mego M,Miskovska V,Palacka P.Phase II study of everolimus in refractory testicular germ cell tumors..Urol Oncol2016;34:122 e17-22

[112] Mueller T,Holzhausen HJ,Albers P.Histological evidence for the existence of germ cell tumor cells showing embryonal carcinoma morphology but lacking OCT4 expression and cisplatin sensitivity..Histochem Cell Biol2010;134:197-204

[113] Mueller T,Luetzkendorf J,Simon H.Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance..Tumour Biol2006;27:71-83

[114] Snow GE,Busch AM,Ewings KE.Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting..BMC Cancer2009;9:383 PMCID:PMC2777936

[115] Timmer-Bosscha H,Meijer C,Mulder NH.Differential effects of all-trans-retinoic acid, docosahexaenoic acid, and hexadecylphosphocholine on cisplatin-induced cytotoxicity and apoptosis in a cisplantin-sensitive and resistant human embryonal carcinoma cell line..Cancer Chemother Pharmacol1998;41:469-76

[116] Honecker F,Harder S,Gillis AJ.Proteome analysis of the effects of all-trans retinoic acid on human germ cell tumor cell lines..J Proteomics2014;96:300-13

[117] Wu YC,Lu SH,Ho HN,Shen CN.Chemotherapeutic sensitivity of testicular germ cell tumors under hypoxic conditions is negatively regulated by SENP1-controlled sumoylation of OCT4..Cancer Res2012;72:4963-73

[118] Abada PB.Cisplatin induces resistance by triggering differentiation of testicular embryonal carcinoma cells..PLoS One2014;9:e87444 PMCID:PMC3903721

[119] Gutekunst M,Weilbacher A,Bedke J.Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct-4..Cancer Res2013;73:1460-9

[120] Koster R.Lessons learned from testicular cancer: identification of cytoplasmic p21 as an Achilles’ heel of cisplatin resistance..Cell Cycle2010;9:4776-7

[121] Buljubašić R,Bojanac AK,Vlahović M.Epigenetics and testicular germ cell tumors..Gene2018;661:22-33

[122] Sonnenburg D,Albany C.Epigenetic Targeting of Platinum Resistant Testicular Cancer..Curr Cancer Drug Targets2016;16:789-95 PMCID:PMC6428575

[123] Koul S,Narayan G,Bacik J.Role of promoter hypermethylation in cisplatin treatment response of male germ cell tumors..Mol Cancer2004;3:16 PMCID:PMC420487

[124] Wermann H,Gillis AJ,van Gurp RJ.Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance..J Pathol2010;221:433-42

[125] Martinelli CMDS,Cárcano FM,Brait M.MGMT and CALCA promoter methylation are associated with poor prognosis intesticular germ cell tumor patients..Oncotarget2016;8:50608-17 PMCID:PMC5584175

[126] Beyrouthy MJ,Hever MP,Eastman A.High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors..Cancer Res2009;69:9360-6 PMCID:PMC2795063

[127] Biswal BK,Hever-Jardine MP,Tomlinson CR.Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation..PLoS One2012;7:e53003 PMCID:PMC3531428

[128] Albany C,von Herrmann KM,Tam J.Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine..Oncotarget2017;8:2949-59 PMCID:PMC5356854

[129] Wongtrakoongate P,Andrews PW.Aza-deoxycytidine induces apoptosis or differentiation via DNMT3B and targets embryonal carcinoma cells but not their differentiated derivatives..Br J Cancer2014;110:2131-8 PMCID:PMC3992495

[130] Oing C,Mansour WY,Dyshlovoy S.F. 5-azacitidine exerts prolonged pro-apoptotic effects and overcomes cisplatin-resistance in non-seminomatous germ cell tumor cells..Int J Mol Sci2018;20:pii: E21 PMCID:PMC6337423

[131] Singh R,Corbet AK,Rodriguez JC.Epigenetic remodeling through downregulation of polycomb repressive complex 2 mediates chemotherapy resistance in testicular germ cell tumors..Cancers (Basel)2019;11:pii: E796

[132] Brinkman AB,Bartels SJ,Matarese F.Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk..Genome Res2012;22:1128-38 PMCID:PMC3371717

[133] Saksouk N,Ziegler-Birling C,Nowak A.Redundant mechanisms to form silent chromatin at pericentromeric regions rely on BEND3 and DNA methylation..Mol Cell.2014;Nov2056:580-94

[134] van Mierlo G,De Clerck L,Huth M.Integrative Proteomic Profiling Reveals PRC2-Dependent Epigenetic Crosstalk Maintains Ground-State Pluripotency..Cell Stem Cell2019;24:123-37e8

[135] Momeny M,Barghi F,Javadikooshesh S.Inhibition of bromodomain and extraterminal domain reduces growth and invasive characteristics of chemoresistant ovarian carcinoma cells..Anticancer Drugs2018;29:1011-20

[136] Zanellato I,Osella D.JQ1, a BET inhibitor, synergizes with cisplatin and induces apoptosis in highly chemoresistant malignant pleural mesothelioma cells..Curr Cancer Drug Targets2018;18:816-28

[137] Jostes S,Fellermeyer M,Hafezi F.The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo..J Cell Mol Med2017;21:1300-14 PMCID:PMC5487916